Search results for "Head and Neck"

showing 10 items of 362 documents

Rupture of supra-aortic neck arteries due to lesions caused by tracheal tubes

1984

Haemorrhages from the common carotid or innominate artery caused by tracheal tubes are rare but dramatic complications of head and neck surgery. Patients with metal tracheostomy cannulas or patients in the phase of wound healing after radical tumour resections of the pharynx and larynx run a greater risk. Following extensive tumour resections and radiation of the upper respiratory and digestive tracts in 680 patients, acute bleeding of the larger neck arteries occurred in 18 patients. In four of these cases, fistulae developed in the innominate or common carotid artery. These ruptures were caused by both plastic and metal tracheal tubes.

AdultMaleLarynxmedicine.medical_specialtyHemorrhagePostoperative Complicationsmedicine.arteryIntubation IntratrachealmedicineHumansCommon carotid arteryRespiratory systemLaryngeal NeoplasmsBrachiocephalic TrunkAgedRupturebusiness.industryPharynxGeneral MedicineMiddle AgedSurgerymedicine.anatomical_structureOtorhinolaryngologyHead and neck surgeryDigestive tractCarotid Artery InjuriesbusinessAortic neckArteryThe Journal of Laryngology & Otology
researchProduct

Quality of life during the first year after partial laryngectomy: Longitudinal study

2018

This prospective study was conducted to assess changes in quality of life (QOL) of patients who undergo a partial laryngectomy.The European Organisation for Research and Treatment of Cancer Quality of Life Questionnaires Core and Head and Neck (EORTC-QLQ-C30, QLQ-HN35) were used preprocedure (n = 218), 1 week (n = 159), 3 months (n = 122), and 1 year after partial laryngectomy (n = 88). Changes over time were analyzed with the Wilcoxon signed rank test and the Holm-Bonferroni method, and interpreted regarding clinical relevance.Most subscales worsened 1 week postprocedure, but many recovered to baseline level after 1 year. Dyspnea and cognitive functioning deteriorated over time, with worst…

AdultMaleLongitudinal studymedicine.medical_specialtyTime FactorsLaryngectomy03 medical and health sciencesPostoperative Complications0302 clinical medicineQuality of lifeSurveys and QuestionnairesHumansMedicineLongitudinal StudiesProspective Studies030223 otorhinolaryngologyProspective cohort studyHead and neckLaryngeal NeoplasmsPartial laryngectomyAgedAged 80 and overbusiness.industryCarcinomaHead and neck cancersocial sciencesMiddle Agedmedicine.diseasehumanitiesOtorhinolaryngology030220 oncology & carcinogenesisQuality of LifePhysical therapyFemalebusinessHead & Neck
researchProduct

A Phase II Study of Levofolinic Acid and 5-Fluorouracil Plus Cisplatin in Patients with Advanced Head and Neck Squamous Cell Carcinoma

1993

Forty patients with advanced squamous cell carcinoma of the head and neck (SCHNC) were treated with a combination of levofolinic acid 100 mg/m2+5-fluorouracil 375 mg/m2 in a 4-hour infusion plus cisplatin 20 mg/m2 in a 2-hour infusion for 5 consecutive days, repeated every 21-28 days. In the group of 20 previously untreated patients, a 90% overall response rate (ORR) with a 30% complete response rate (CRR) was obtained. In the group of 20 pretreated patients with recurrent and/or metastatic SCHNC, a 55% ORR with 15% CRR was achieved. This treatment was given on an outpatient basis and was generally very well tolerated with only 2 patients requiring hospitalization. Grade 1-2 gastrointestina…

AdultMaleOncologyCancer Researchmedicine.medical_specialtyPathologymedicine.medical_treatmentLeucovorinPhases of clinical researchInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansIn patientHead and neckAgedNeoplasm StagingCisplatinChemotherapybusiness.industryStereoisomerismGeneral MedicineMiddle Agedmedicine.diseaseCombined Modality TherapyHead and neck squamous-cell carcinomaOncologyHead and Neck NeoplasmsFluorouracilCarcinoma Squamous CellFemaleFluorouracilCisplatinbusinessLevofolinic acidmedicine.drugOncology
researchProduct

Overexpression of GLUT-1 is associated with resistance to radiotherapy and adverse prognosis in squamous cell carcinoma of the oral cavity

2006

This study tested the hypothesis that GLUT-1 is a marker of radioresistance in oral squamous cell carcinomas (OSCC). A GLUT-1 labeling index (LI) was determined by immunohistochemistry in 40 pretreatment OSCC biopsies. Radiation responses were categorized by histopathology of the resection specimens. Associations between the LI and radiation response, Kaplan-Meier survival estimates and Cox regression analysis for the variables GLUT-1, T-stage, N-stage and chemotherapy were examined. The median LI was 64.2% (range 14-100%). Tumors with65% of GLUT-1+cells were more resistant to radiation (p=0.023). Overall survival was higher (p=0.044) for subjects with low LI (median value) than those with …

AdultMaleOncologyendocrine systemCancer Researchmedicine.medical_specialtyPathologymedicine.medical_treatmentAntineoplastic AgentsRadiation ToleranceImmunoenzyme TechniquesRadioresistanceInternal medicineBiomarkers TumorHumansMedicineAgedRetrospective StudiesGlucose Transporter Type 1Chemotherapybusiness.industryProportional hazards modelHead and neck cancerMiddle AgedPrognosismedicine.diseaseCombined Modality TherapySurvival AnalysisNeoplasm ProteinsRadiation therapystomatognathic diseasesTreatment OutcomeOncologyEpidermoid carcinomaCarcinoma Squamous CellImmunohistochemistryFemaleMouth NeoplasmsHistopathologyOral Surgerybusinesshormones hormone substitutes and hormone antagonistsOral Oncology
researchProduct

DNA measurements for monitoring chemotherapy in advanced head and neck carcinomas

1994

Background. Quantitative DNA measurements have demonstrated prognostic relevance in various malignancies, including head and neck cancer. The application of DNA measurements in monitoring and predicting the outcome of chemotherapy in treating patients with head and neck cancer was investigated. Methods. Twenty-five patients with advanced squamous cell carcinomas of the head and neck who underwent primary chemotherapy with three courses of cisplatin and 5-fluorouracil (5-FU) were examined in this study. Cytologic smears from the tumor site, as well as from normal mucosa, were taken before and 1 week after each course of chemotherapy. Quantitative DNA measurements were performed using an auto…

AdultMaleOncologymedicine.medical_specialtyPathologymedicine.medical_treatmentCellchemistry.chemical_compoundText miningCytologyInternal medicinemedicineHumansAgedCisplatinChemotherapybusiness.industryRemission InductionHead and neck cancerHistologyDNA NeoplasmMiddle AgedPrognosismedicine.diseaseTreatment Outcomemedicine.anatomical_structureOtorhinolaryngologychemistryHead and Neck NeoplasmsCarcinoma Squamous CellFemaleDrug MonitoringbusinessDNAmedicine.drugHead & Neck
researchProduct

Methotrexate, Vinblastine, Epidoxorubicin, and Bleomycin as Second-Line Chemotherapy for Recurrent and/or Metastatic Squamous Cell Carcinoma of the H…

1994

Thirty evaluable patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck region previously treated with cisplatin-based chemotherapy were treated with a combination of methotrexate, vinblastine, epidoxorubicin, and bleomycin as second-line chemotherapy. Besides surgery and/or radiotherapy all patients had previously received chemotherapy as induction therapy or as palliation for recurrent disease. Only 20% of patients achieved a partial objective response with a mean duration of 5.6 months (range 3.2-6.2), and 30% of patients had a stabilization of disease with a mean duration of 4.2+ months (range 3.8-6.0). Patients who responded had rhinopharyngeal carcinoma…

AdultMaleOncologymedicine.medical_specialtyVomitingmedicine.medical_treatmentVinblastineBleomycinSecond line chemotherapyMetastasisBleomycinchemistry.chemical_compoundInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansBasal cellHead and neckAgedEpirubicinCisplatinStomatitisChemotherapybusiness.industryPalliative CareRemission InductionHead and neck cancerLeukopeniaMiddle Agedmedicine.diseaseCombined Modality TherapySurvival RateMethotrexateOtorhinolaryngologychemistryHead and Neck NeoplasmsCarcinoma Squamous CellFemaleFluorouracilCisplatinNeoplasm Recurrence Localbusinessmedicine.drugORL
researchProduct

Management of head and neck paragangliomas: review of 120 patients.

2008

Head and neck paragangliomas (PGL) are rare, mostly benign tumors. About 10% to 15% of PGL are caused by mutations in the succinate dehydrogenase genes B, C, or D and may appear multifocally.A retrospective review of 120 patients with 146 head and neck PGL, including 46 carotid body tumors (CBT), 13 vagal tumors, 55 jugulotympanic tumors (JTT), 25 tympanic tumors (TT) and 7 tumors in other locations are included. The internal carotid artery was preserved in 97.5% of CBT resections. Preservation of hearing was achieved in 92% of JTT and 88% of TT resections.According to our experience, the treatment of PGL must be individualized, taking into account the patient's age, medical condition, tumo…

AdultMalePathologymedicine.medical_specialtyAdolescentCarotid arteriesmedicine.medical_treatmentOutcome assessmentDeafnessParagangliomaYoung AdultNeoplasm RecurrencePostoperative ComplicationsParagangliomaOutcome Assessment Health CaremedicineHumansEmbolizationHead and neckChildAgedRetrospective StudiesAged 80 and overbusiness.industryMiddle Agedmedicine.diseaseEmbolization TherapeuticCranial Nerve DiseasesRadiation therapyOtorhinolaryngologyHead and Neck NeoplasmsFemaleRadiotherapy AdjuvantNeoplasm Recurrence LocalbusinessCarotid Artery InternalHeadneck
researchProduct

Cytotoxic and genotoxic effects of electronic cigarette liquids on human mucosal tissue cultures of the oropharynx

2016

The popularity of electronic cigarettes (ECs) is rapidly growing and ECs are claimed to be an uncritically regarded alternative to conventional cigarettes. The mucosal tissue of the upper aerodigestive tract (UADT) is the first contact organ for xenobiotics such as liquids of ECs. The aim of this study is to investigate the bimolecular effects of e-liquids on human pharyngeal tissue cultures to evaluate whether e-liquids and their components present a risk factor for head and neck squamous cell carcinoma. Fresh tissue samples of healthy oropharyngeal mucosa were assembled into mucosal tissue cultures. Two fruit-flavored liquids (FLs), one tobacco-flavored liquid (TL) (all containing nicotin…

AdultMalePathologymedicine.medical_specialtyOropharyngeal TissueDNA damageCell SurvivalHealth Toxicology and MutagenesisOropharynxElectronic Nicotine Delivery SystemsToxicologyPathology and Forensic Medicine03 medical and health sciencesTissue cultureYoung Adult0302 clinical medicineFresh TissueRisk FactorsGermanyMedicineHumansCarcinogenMucous Membranebusiness.industryCytotoxinsSquamous Cell Carcinoma of Head and NeckGeneral Medicinemedicine.diseaseHead and neck squamous-cell carcinoma3. Good health030228 respiratory systemHead and Neck NeoplasmsToxicityCancer researchCarcinoma Squamous CellDNA fragmentationFemalebusiness030217 neurology & neurosurgeryDNA DamageMutagens
researchProduct

Bovine pericardium based non-cross linked collagen matrix for successful root coverage, a clinical study in human

2012

Abstract Introduction The aim of this study was to clinically assess the capacity of a novel bovine pericardium based, non-cross linked collagen matrix in root coverage. Methods 62 gingival recessions of Miller class I or II were treated. The matrix was adapted underneath a coronal repositioned split thickness flap. Clinical values were assessed at baseline and after six months. Results The mean recession in each patient was 2.2 mm at baseline. 6 Months after surgery 86.7% of the exposed root surfaces were covered. On average 0,3 mm of recession remained. The clinical attachment level changed from 3.5 ± 1.3 mm to 1,8 ( ± 0,7) mm during the observational time period. No statistically signifi…

AdultMalePathologymedicine.medical_specialtylcsh:Specialties of internal medicineBovine pericardiumClinical NeurologyConnective tissueMatrix (biology)Gingival recessionClinical studylcsh:RC581-951medicineAnimalsHumansroot coverageddc:610Tooth RootGeneral Dentistryconnective tissueTissue Scaffoldsbusiness.industryDentistry(all)Researchguided tissue regenerationAnatomycollagen matrixMiddle Agedbovine pericardiumRoot coveragemedicine.anatomical_structureOtorhinolaryngologycardiovascular systemHead and neck surgeryGuided Tissue Regeneration PeriodontalCattleFemaleNeurology (clinical)CollagenbusinessPericardiumHead & Face Medicine
researchProduct

Factors associated with the quality of life of subjects with facial disfigurement due to surgical treatment of head and neck cancer

2018

Background Facial disfigurement has been considered one of the most challenging consequences of the surgical treatment for head and neck cancer patients, mainly due to the importance of the facial region for the personal identity, body self-image and interpersonal interactions, which might affect negatively the quality of life. The aim of this study was to assess factors associated with the quality of life of subjects with facial disfigurement due to surgical treatment. Material and Methods Clinical data were retrieved from 103 patient’s medical records and quality of life data were collected using the Functional Assessment of Cancer Therapy (FACT-H&N) questionnaire. Moreover, the degree of…

AdultMalePediatricsmedicine.medical_specialtyCross-sectional studyAffect (psychology)03 medical and health sciencesPostoperative Complications0302 clinical medicineQuality of lifeHumansMedicinePatient Reported Outcome MeasuresSurgical treatmentGeneral DentistryAgedAged 80 and overOral Medicine and Pathologybusiness.industryResearchMedical recordHead and neck cancer030206 dentistryMiddle Aged:CIENCIAS MÉDICAS [UNESCO]Disfigurementmedicine.diseaseCross-Sectional StudiesOtorhinolaryngologyHead and Neck NeoplasmsFace030220 oncology & carcinogenesisFacial disfigurementUNESCO::CIENCIAS MÉDICASQuality of LifeFemaleSurgerybusiness
researchProduct